Search

everythinglearnresearchcommunity

for

Search:↓

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

Excessive pre-ejaculation can be treated with certain medications.

Finasteride effectively treats male hair loss, increasing length and thickness.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Dermatologists should guide patients on blood donation timing due to various eligibility criteria.

Italian guidelines recommend using trichoscopy for diagnosis and treatments like minoxidil for hair loss.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

5-α-reductase inhibitors, intralesional steroids, and hydroxychloroquine are the most effective treatments for frontal fibrosing alopecia.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.